Dako and Cytomation join operations
This article was originally published in Clinica
Executive Summary
Danish diagnostic company Dako is to combine operations with Cytomation, of Fort Collins, Colorado. The deal brings together Cytomation's bioinstrumentation and software with Dako's biotech and diagnostic experience. The unit will be headed by Copenhagen-based Dako's president and CEO, Jes Estergaard, while Nigel Ferrey, Cytomation's president and CEO, will be responsible for US operations. He will also join the corporate management group.